MRI prostate contouring is not impaired by the use of a radiotherapy image acquisition set-up. An intra- and inter-observer paired comparative analysis with diagnostic set-up images.


Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 21 03 2020
revised: 09 04 2020
accepted: 14 05 2020
pubmed: 12 1 2021
medline: 7 4 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

The use of MRI for radiotherapy planning purposes is growing but image acquisition using radiotherapy set-ups has impaired image quality. Whether differences in image acquisition set-up could modify organ contouring has not been evaluated. Therefore, we aimed to evaluate differences in contouring between paired of image sets that were acquired in the same scanning session using different parameters. Ten patients underwent RT treatment planning with MRI co-registration. MRI was carried out using two different set-ups during the same session, MRI radiotherapy set-ups and MRI diagnostic set-ups. Prostates and rectums were retrospectively contoured in both image sets by 5 radiation oncologists and 4 radiologists. Intra-observer analysis was carried out comparing organ volumes, the Dice coefficient and hausdorff distance values between two contouring rounds. Inter-observer analysis was carried out by comparing individual contours to a generated STAPLE consensus contour, which is considered the gold standard reference. No significant differences were observed between MRI acquisition set-ups. Significant differences were observed for the dice and hausdorff parameters, comparing individual contours to the STAPLE consensus contour, when analysing diagnostic images between rounds, although raw values were similar. Prostate and rectum contours did not differ significantly when using diagnostic or radiotherapy MRI acquisition set-ups.

Identifiants

pubmed: 33423967
pii: S1278-3218(20)30327-9
doi: 10.1016/j.canrad.2020.05.024
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-113

Informations de copyright

Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

S Sabater (S)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain. Electronic address: ssabaterm@gmail.com.

M R Pastor-Juan (MR)

Department of radiology, Complejo hospitalario universitario de Albacete (CHUA), Albacete, Spain.

I Andres (I)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

L López-Martinez (L)

Department of radiology, Complejo hospitalario universitario de Albacete (CHUA), Albacete, Spain.

V Lopez-Honrubia (V)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

M I Tercero-Azorin (MI)

Department of radiology, Complejo hospitalario universitario de Albacete (CHUA), Albacete, Spain.

M Sevillano (M)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

E Lozano-Setien (E)

Department of radiology, Complejo hospitalario universitario de Albacete (CHUA), Albacete, Spain.

E Jimenez-Jimenez (E)

Department of radiation oncology, hospital universitario Santa Lucia, Cartagena, Spain.

R Berenguer (R)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

A Rovirosa (A)

Gynecological cancer unit, radiation oncology department, ICMHO, IDIBAPS, university of Barcelona, hospital clinic, Barcelona, Spain.

S Castro-Larefors (S)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

M Magdalena Marti-Laosa (M)

Department of radiation oncology, Complejo hospitalario universitario de Albacete (CHUA), C/Hnos Falcó 37, 02006 Albacete, Spain.

O Roche (O)

Laboratorio de oncología, unidad de medicina molecular, unidad asociada de biomedicina UCLM, unidad asociada al CSIC, centro regional de investigaciones biomédicas, universidad de Castilla-La Mancha, Albacete, Spain; Departamento de ciencias médicas, facultad de medicina de Albacete, universidad de Castilla-La Mancha, Albacete, Spain.

F Martinez-Terol (F)

Complejo hospitalario universitario de Albacete (CHUA), Albacete, Spain.

M Arenas (M)

Department of radiation oncology, hospital universitari Sant Joan, Reus, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH